OBJECTIVES: To examine the influence of different surgical procedures on clinical outcome in patients undergoing aortic root replacement for ascending aorta aneurysm (AAA) with or without concomitant aortic valve regurgitation (AR).
INTRODUCTION
The complete replacement of the aortic root and the aortic valve, first described by Bentall and De Bono [1] in the late 1960s, represents the standard surgical procedure for patients with a stenotic aortic valve and concomitant aortic root aneurysm. On the other hand, in patients presenting with aortic root dilatation with or without concomitant aortic valve regurgitation, but morphologically intact aortic cusps, the Bentall procedure has been competed by different aortic valve-sparing procedures during the last decade. The most widespread techniques are the remodelling of the aortic root described by Sarsam and Yacoub and the reimplantation of the aortic valve described by David and Feindel [2, 3] . The goal of these valve-sparing root replacement (VSRR) procedures was to preserve the functionality and superior haemodynamics of the native aortic valve, while avoiding the typical complications associated with mechanical or biological prostheses.
The aim of the present study was to assess which surgical strategy represents the best option in patients with aortic root aneurysm, with or without concomitant aortic valve regurgitation, in order to optimize the long-term outcome.
PATIENTS AND METHODS

Patient selection and data collection
This study was approved by the Ethics Committee of the Technische Universitaet Muenchen, Munich. Between April 2000 and June 2011, 941 patients underwent replacement of the ascending aorta for aortic aneurysm with or without concomitant aortic valve regurgitation (AR) at the German Heart Centre Munich. On account of a different pathophysiology, patients who underwent Bentall operation for stenotic aortic valve with post-stenotic aortic dilatation during the same period were excluded from the present study (n = 145), as were patients who underwent a supracoronary replacement of the ascending aorta (n = 424), with or without aortic valve replacement. Furthermore, neonates and infants less than 1 year of age were excluded from the present study (n = 2). Three hundred and seventy patients, finally representing the study cohort, underwent aortic root replacement for AAA with or without concomitant AR.
Preoperative echocardiographic data were available for all patients. The degree of pre-and postoperative AR was determined by transthoracic or transoesophageal echocardiography. Regurgitation of the aortic valve was graded as none, I°, II°, III°and IV°. The aortic root and valve annulus diameter were measured by computed tomography or echocardiography. The ventricular function was graded using two-dimensional echocardiography and evaluated as normal (ejection fraction ≥50%), moderately impaired (ejection fraction 30-49%) or severely impaired (ejection fraction <30%). All patients were prospectively studied with annual clinical assessment and echocardiography.
Study groups
There were 272 (73.5%) male and 98 (26.5%) female patients, with a mean age of 52.19 ± 16.44 years (range from 2.94 to 87.66 years). The patients were assigned to three different groups according to the surgical procedure: aortic VSRR (Group A; n = 178), Bentall procedure with a biological conduit (Group B; n = 91) and Bentall procedure with a mechanical conduit (Group C; n = 101). Patients in whom aortic valve-sparing procedures were converted to Bentall procedures during the operation, because of advanced deterioration of the aortic valve, were included in one of the Bentall procedure groups, according to the implanted prosthesis. Table 1 summarizes the demographic data of all patients according to the surgical procedure.
Forty-two (11.4%) patients presented with Marfan's syndrome, which was diagnosed according to the Ghent criteria or by genetic testing postoperatively. Twelve (3.2%) patients were less than 18 years of age at time of the operation. Sixty-two (16.7%) patients underwent emergent operation on the day of admission to our hospital. Fifty-four (14.6%) patients had undergone one or more previous cardiac interventions such as mitral valve repair or replacement (n = 7), tricuspid valve repair or replacement (n = 3), aortic valve repair or replacement (n = 12), aortocoronary bypass operation (n = 3), Ross operation (n = 2), CoA resection (n = 6), atrial septal defect (ASD)/ventricular septal defect (VSD) closure (n = 7), Senning operation (n = 1), double outlet right ventricle correction (n = 2), Blalock-Taussig shunt implantation (n = 2), Bentall operation (n = 2), supracoronary ascending aorta replacement (n = 8), Yacoub operation (n = 4), aortic arch replacement (n = 1), descending aorta replacement or stent implantation (n = 6) and Maze operation (n = 2).
A bicuspid aortic valve (BAV) was diagnosed in 67/370 (18.1%) patients. Among the patients who presented with a BAV, AR was absent in 2.9% (2/67), AR I°was detected in 7.5% (5/67), II°in 25.4% (17/67), III°in 44.8% (30/67) and IV°in 19.4% (13/67). In 303/370 (81.9%) patients who presented with a tricuspid aortic valve, AR was graded as I°in 10.2% (31/303), II°in 31.1% (94/303), III°in 45.2% (137/303) and IV°in 9.9% (30/303) respectively. AR was not evaluated in 3.6% (11/303).
Three hundred and thirty-five of 370 (90.5%) patients presented with sinus rhythm, 33 (8.9%) with atrial fibrillation and 2 (0.6%) with pacemaker rhythm. The 10 patients summarized in Table 1 with congenital heart disease presented with concomitant atrial septal defect or patent foramen ovale (n = 4), persistent ductus arteriosus (n = 1), VSD (n = 4) and CoA (n = 1).
Surgical technique
At the beginning of the enrolment period, our surgical strategy was mostly based on the experience of the operating surgeon with the different root replacement techniques. Furthermore, VSRR procedures were accomplished only in patients with morphologically intact tricuspid valves, at most moderate valve regurgitation, and only in elective patients. However, because the results were encouraging, we changed our surgical strategy over the last decade, extending the indications for VSRR.
Operations for aortic root replacement were performed by means of a median sternotomy using standard cardiopulmonary bypass with moderate hypothermia (32°C). Cardiopulmonary arrest with deep hypothermia (24°C) and selective antegrade cerebral perfusion was used if aortic arch or hemiarch replacement was necessary. Cold crystalloid cardioplegia (Bretschneider solution, Custodiol; Dr Köhler Chemie, Germany) was infused in an antegrade fashion with repetition every 60 min.
In the group of patients who underwent a VSRR, a remodelling of the aortic root was performed in 26 (14.6%), and reimplantation of the aortic valve in 152 (85.4%) patients. No particular clinical or echocardiography parameters were used to select the type of aortic valve-sparing operation. Starting in 2000, the remodelling technique was performed by replacing the dilated aortic root with a scalloped tubular Dacron graft using a single suture line above the surgical annulus and thus creating artificial sinuses of Valsalva as described by Yacoub and co-workers [3] . Starting in 2003, the reimplantation technique was performed in the vast majority of patients. Aortic valve reimplantation procedure was performed as described by David and co-workers [2, 4] : resection of the aortic sinuses, implantation of the aortic valve annulus and subcommissural triangles of the non-coronary cusp inside a Valsalva graft (Vascutek) using two proximal suture lines, one subannular mattress suture line and one haemostatic continuous suture line within the graft.
A modified Bentall operation was performed in 192 patients. In 91 patients, a biological valve was implanted. One hundred and one patients received a mechanical composite conduit. The diseased aortic wall and the native valve were resected. Consecutively, the coronary buttons were excised out of the corresponding sinus of Valsalva. The sewing ring of the valved conduit was secured to the aortic annulus with interrupted pledgeted mattress sutures. Finally, the coronary ostia were directly reimplanted in the vascular graft.
In all patients, the distal part of the conduit was anastomosed to the divided aorta and, if necessary, reinforced with one or two 
Follow-up
Follow-up was conducted annually for the patients from the VSRR group. The final follow-up for both, the VSRR group and the Bentall group, was conducted by mail questionnaire and telephonic interview with the patient and the referring cardiologist.
Clinical and echocardiographic assessments were accomplished by the referring cardiologist or in our clinic. The latest follow-up examinations included ECG, Doppler echocardiography and physical examination. Follow-up was complete in 91.4% of patients. The mean follow-up was 4.3 years (range 1 month to 12 years), corresponding to a cumulative follow-up of 1551.4 patient years. The functional status was determined according to the New York Heart Association (NYHA) class. The cause of death was determined from hospital records.
Statistical analysis
Categorical variables were reported using the number and percentage of observations. Continuous variables were reported as means ± standard deviation or median with ranges. Categorical variables were compared using the χ 2 test and generalized Fisher's exact test (Freeman-Halton test), respectively. Differences of continuous parameters were statistically assessed by univariate analysis of variance or the Kruskal-Wallis test, if appropriate. The outcome parameters were defined as time from the primary operation to death or to aortic valve-related reoperation. The probability of freedom from events was estimated according to the Kaplan-Meier analysis. Freedom-from-events curves were compared using the log-rank test. A P-value of <0.05 was considered statistically significant. Univariable and multivariable associations were analysed by using a Cox's proportional hazards model. Models were generated with a forward stepwise analysis. Factors with a P-value of ≤0.05 in the univariable analysis were entered into the multivariable analysis. Analyses were performed with SPSS 21.0 for Windows.
RESULTS
Operative characteristics
The prostheses used in the group of patients who received a biological conduit (n = 91) were Biovalsalva biological valved conduit (Vascutek, Renfrewshire, UK), Hancock biological valved conduit (Medtronic, Minneapolis, MN, USA) and Toronto root (SJM, St. Paul, Minnesota, USA) in 53, 26 and 12 patients, respectively.
The prostheses used in the group of patients who received a mechanical conduit (n = 101) were St. Jude Medical conduit (SJM, St. Paul, MN, USA) and Carbomedics Carbo-Seal conduit (Sorin, Milano, Italy) in 86 and 15 patients, respectively.
The prosthesis used in the group of patients who underwent an aortic valve-sparing operation (n = 178) were Vaskutec Gelweave Valsalva (Vascutek, Renfrewshire, UK), Hemashield (Maquet, Rastatt, Germany) and Braun Uni-Graft W Protheses (B. Braun Melsungen, Melsungen, Germany) in 126, 50 and 2 patients, respectively.
Fifty-nine of 178 (33.1%) patients who received a valve-sparing operation underwent a concomitant aortic valve repair by means of free edge plication or triangular resection in elongated cusps combined with subcommissural annuloplasty, if necessary.
One or more concomitant procedures, excluding the aortic valve repairs, were performed in 138/370 (37.3%) patients and included coronary artery bypass grafting in 60/370 (16.2%) patients, mitral valve operation in 15/370 (4.1%) patients, tricuspid valve operation in 6/370 (1.6%), aortic arch or hemiarch replacement in 52/370 (14.1%) patients, subvalvular myectomy in 17/370 (4.6%) patients, ASD or VSD closure in 5/370 (1.4%) patients and antegrade stenting of the descending aorta in 7/370 (1.9%) patients. Coronary artery bypass grafting was necessary not only in The values are denoted as mean ± SD or n (%). AR: aortic regurgitation; AV: aortic valve; NYHA: New York Heart Association.
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C.C. Badiu et al. / European Journal of Cardio-Thoracic Surgerypatients with coronary artery disease but also in patients with coronaries affected by the aortic dissection. The overall mean aortic cross-clamp time and the total cardiopulmonary bypass time for the study group were 122 ± 35 and 165 ± 57 min, respectively. Operative data according to the surgical procedure are depicted in Table 2 .
Survival
There were 3 operative deaths in the study cohort, of which all presented with acute type A aortic dissection. Two of these patients underwent a modified Bentall operation with biological conduit and one a valve-sparing operation. All of them presented with extensive dissection of the aortic wall and had very frail aortic tissue. The cause of death in all 3 patients was uncontrollable massive intraoperative bleeding. Fourteen patients died during the initial hospitalization from postoperative low output syndrome in 6, rupture of the descending aorta in 1, cerebral haemorrhage in 3, refractory ventricular fibrillation in 2 and electromechanical dissociation in 2. Ten out of the fourteen patients who died during the initial hospitalisation had undergone emergency operations because of an acute type A aortic dissection. Thirty-three patients died after discharge from the hospital during the follow-up period: 10 patients from cardiac insufficiency, 1 from aortic rupture, 2 from cerebral haemorrhage, 7 from refractory ventricular fibrillation, 2 from sudden death, 5 from multiple organ failure, 2 from electromechanical dissociation and 2 from myocardial infarction. Two patients who died of non-cardiac-related causes were excluded from the mortality calculation.
Overall actuarial 5-year and 8-year survival rates were 86.5 ± 2.1 and 82.6 ± 2.8%, respectively. Estimated 5-year survival probability rates for Groups A, B and C were 95.2 ± 1.8, 80.9 ± 4.4 and 79.3 ± 4.5%, respectively (P < 0.01; log-rank).
In patients who underwent elective operations, estimated 5-year survival probability rates for Groups A, B and C were 96.1 ± 1.8, 88.9 ± 4.4 and 82.3 ± 4.9%, respectively (log-rank; P = 0.02). Furthermore, excluding the operative and in-hospital deaths, which may not be related to the surgical procedure, the difference between the groups still remains significant. Accordingly, excluding the early deaths in patients who underwent elective operations, estimated 5-year survival probability rates for Groups A, B and C were 97.6 ± 1.4, 90.8 ± 4.1 and 84.3 ± 4.6%, respectively (log-rank; P = 0.03) (Fig. 1) . Comparing the VSRR group only with the group of patients who underwent a modified Bentall operation with a mechanical conduit, the difference in survival remains significant (P < 0.01).
In the univariable analysis, previous operation (odds ratio [OR]: 3.00, 95% confidence interval [95% CI] 1.166-5.748, P < 0.01), emergency operation (OR: 3.52, 95% CI 1.931-6.423, P < 0.01), age (OR: 1.023, 95% CI 1.003-1.043, P = 0.03), any concomitant procedure (OR: 3.95, 95% CI 1.684-5.550, P < 0.01) and aortic cross-clamp time (OR: 1.10, 95% CI 1.006-1.019, P < 0.01) were identified as univariable predictors for mortality. Survival was significantly in favour of the VSRR group (OR: 0.158, 95% CI 0.062-0.402, P < 0.01).
On multivariable analysis, only previous operations (OR: 3.10, 95% CI 1.505-6.417, P < 0.01) and emergency procedures (OR: 2.24, 95% CI 1.129-4.480, P = 0.02) remained as independent predictors for mortality. Again, survival was in favour of the VSRR group (OR: 0.26, 95% CI 0.089-0.782, P = 0.02).
Reoperations
During the initial hospitalization, 2 patients underwent a reoperation on the aortic valve for early recurrent AR. The first patient was diagnosed with a circumflex artery anomaly. Early after the operation, the patient suffered myocardial ischaemia due to torsion of the circumflex artery, with the consequence of an impaired ventricular function. Owing to a surgical failure of the Yacoub procedure, the patient developed, early after the operation, also severe AR. Eleven days after primary operation, the patient underwent a modified Bentall procedure with a mechanical valved conduit. The second patient had had a David procedure with aortic valve repair as a primary operation. Severe recurrent AR developed early after the operation, and an aortic valve replacement with a mechanical prosthesis was performed. After hospital discharge, further 12 patients underwent a reoperation for aortic valve-related disorders. Eight of these 12 patients had undergone an aortic valve-sparing operation: 4 reimplantation and 4 remodelling procedures. The other 4 patients had undergone a modified Bentall procedure, 2 with a mechanical and 2 with a biological valved conduit. The data The values are denoted as mean ± SD or n (%). MV: mitral valve; TV: tricuspid valve.
of the patients who underwent a reoperation during the follow-up period and the reasons for reoperation are depicted in Table 3 . All 14 patients who underwent a reoperation were alive at the time of the final follow-up. Overall freedom from valve-related reoperation at 5 and 8 years were 94.3 ± 1.9 and 92.3 ± 2.7%, respectively, without being significantly different between the three groups (P = 0.13). The estimated 5-year freedom from reoperation probability was 87.9 ± 5.4% for Group A, 98.3 ± 1.7% for Group B and 96.6 ± 2.4% for Group C (Fig. 2) .
Marfan disease (OR 3.38, 95% CI 1.040-11.004, P = 0.04) and VSRR (OR 3.78, 95% CI 1.113-12.855, P = 0.03) were identified as univariable predictors for reoperation on the aortic valve, but were not reconfirmed as independent predictors in the multivariate Cox regression analysis.
Thromboembolic, neurological events and endocarditis
For the entire study population, the overall actuarial freedom from thromboembolic events was 93.6 ± 2.0% (P = 0.53), the corresponding estimated 5-year probability for freedom from any neurological event was 91.5 ± 2.0% (P = 0.93) and the overall actuarial freedom from endocarditis was 96.1 ± 1.5% (P = 0.46). No significant differences of these parameters between the groups were detected.
Major bleeding events
The overall actuarial freedom from major bleeding events was significantly different (P = 0.03) between the 3 patient groups. The corresponding estimated 5-year probability was 97.2 ± 1.3% for the entire study population, 99.3 ± 0.7% for the VSRR, 100% for the group of patients who underwent the Bentall procedure with a biological conduit and 93 ± 3.4% for the group of patients who underwent the Bentall procedure with a mechanical conduit (Fig. 3) .
Aortic valve function
At the time of the last echocardiographic follow-up, AR was absent in 35.9% of the study patients, AR I°was present in 43.6% and AR II°in 10.25% of the study patients. Aortic valve function was not described in 10.25% of the patients who were alive at the last follow-up. Significant aortic valve stenosis was not detected in any patient.
DISCUSSION
The Bentall procedure used to be the 'gold standard' for patients with aortic root or ascending aorta aneurysm or dissection, with or without concomitant AR. However, valve prostheses-related complications are frequent and thus, several aortic VSRR procedures have been developed in the past [5] . The most commonly performed procedures are the remodelling of the aortic root, also referred to as the Yacoub procedure and the reimplantation of the aortic valve known as David procedure. The aim of VSRR operations was to preserve and restore the native aortic valve, which yields superior haemodynamics compared with biological or mechanical valve prostheses. Furthermore, in young patients who otherwise would need a mechanical prosthesis, the preservation of the native valve obviates the need for life-long anticoagulative therapy. Nevertheless, the decision of whether to repair or replace the valve in case of aortic valve regurgitation still remains controversial, all the more in younger patients in whom the replacement of the aortic valve with a mechanical prosthesis promises to be a lifetime solution. Despite the complexity of this debate, there are only a few reports in the literature comparing the clinical outcome of patients after either Bentall or aortic VSRR operations [6] [7] [8] [9] [10] .
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In the present study, survival was in favour of the VSRR group. Furthermore, the putative limitation of a higher need for reoperation in the long term in patients undergoing a VSRR could not be confirmed. Freedom from reoperation on the aortic valve was not significantly different between the three groups of patients. Although Marfan disease and valve-sparing operation were identified as univariable predictors for reoperation on the aortic valve, the two factors were not confirmed as independent predictors for reoperation in the multivariate Cox regression analysis. Furthermore, we identified factors as previous cardiac operations and emergency operation as independent predictors for mortality, regardless of the procedure performed.
The heterogeneity of Group B to the other patients, who were younger and had less comorbidities, may weaken the statistical comparison between the valve-sparing procedures and the Bentall procedure with a biological valved conduit. However, due to similar baseline characteristics, a statistical comparison of the mechanical Bentall group with the VSRR group is justified. Like in our study, literature reports demonstrate a superior outcome for patients undergoing aortic VSRR as opposed to the Bentall procedure. Even if the reported higher survival rates did not reach statistical significance in all studies, a tendency towards a better survival for valve-sparing patients is broadly recognizable [6] [7] [8] [9] . Furthermore, the superiority of VSRR procedures is reconfirmed also by the significant lower rates of valve-related complications.
In a similar study recently published by Kallenbach et al., age, gender, creatinine level, NYHA class and chronic obstructive pulmonary disease at the time of operation were determined as risk factors for long-term mortality [8] . The authors compared 548 patients who were assigned to four groups: 298 (54%) patients had Bentall operation; 154 (28%) underwent only a supracoronary replacement of the ascending aorta, with or without valve replacement; 96 (21%) received VSRR using the David technique and 13 (3%) underwent VSRR using the Yacoub technique. The authors report overall mortality rates of 91 ± 1.5, 78 ± 3.8 and 69 ± 5.7% at 5, 10 and 15 years, respectively. Although the Kaplan-Meier analysis reveals superior early survival rates in the David group, the authors do not report the long-term survival data for the different groups, because of the small number of reimplantation procedures and a short follow-up period in these patients. Considering the heterogeneity, which is to be expected in patients presenting with these pathologies, the authors conclude that an individual treatment strategy has to be developed for every patient with respect to specific pathology.
Lim et al. reviewed 120 patients who underwent surgery for root dilatation with moderate to severe AR [9] . Forty-eight of these patients underwent valve-sparing procedures and 72 underwent a Bentall operation. After a mean follow-up time of 4.9 years, the authors calculated a 5-year survival of 88.4 ± 5.2% in the Bentall group and 90.8 ± 4.4% in the valve-sparing group. The difference was not statistically significant as were incidences of valve-related complications. Nevertheless, due to a higher rate of reoperations for recurrent significant AR in the valve-sparing group, the authors recommend caution when sparing aortic valves with advanced regurgitation. In contrast to our group, the group reported by Lim et al. as valve-sparing cohort consisted only 10 patients who underwent a David procedure, whereas the remaining 38 patients underwent only a reduction of the sinotubular junction. Because of this methodological limitation of the study reported by Lim, their results may be affected and the power of the conclusion reduced.
In the study recently reported by Dias et al. [6] , the authors presented a cohort of 164 patients who underwent either a mechanical composite root replacement (n = 129) or a valve-preserving operation (n = 39). They reported a significantly higher early mortality rate in patients undergoing a Bentall operation. Nevertheless, in the long term, the authors could demonstrate only a trend towards better survival after valve-sparing procedures. Actuarial survival at 7 years was higher for patients with spared aortic valves (93.5%) compared with complete root replacement (77.6%). Furthermore, Dias et al. reported significantly higher rates for valve-related complications in patients undergoing root replacement with a mechanical valved conduit. They conclude that the advantage of valve-preserving operation consist not only in higher long-term survival rates but also in reduced valve-related complications such as haemorrhage or thromboembolism. We also identified significantly higher rates for major bleeding events for patients undergoing Bentall operation with a mechanical conduit when compared with those undergoing Bentall with a biological conduit or those with valve-preserving root operation. Even with modern anticoagulation therapy regimens, including self-control devices, haemorrhagic complications still play a major role in patients after root replacement with mechanical conduits. Accordingly, surgeons should be encouraged to favour native valve-sparing procedures whenever it is technically feasible. However, in the era of valve-in-valve transcatheter procedures, biological conduit implantation may be considered even in patients younger than 65 years of age, in order to avoid late bleeding complications.
Franke et al. [7] compared the data of 143 patients who received either an aortic composite replacement (n = 67) or a David operation (n = 76). The authors included patients with aortic valve stenosis in their analysis. They reported a higher survival rate in the David group after 3 years (91.9 vs 81.1%). Furthermore, the incidence of serious adverse events during the study period was significantly higher in the group of patients who underwent a Bentall procedure (28.35 vs 10.8%, P = 0.008). A comparison between patients who underwent aortic root composite replacement with either mechanical or biological prostheses was not provided by the authors.
STUDY LIMITATIONS
The main limitation was that the present evaluation was subject to the restrictions of a retrospective study, in that the echocardiographic follow-up was not 100% possible in our clinic. Another main limitation was that the preoperative characteristics of enrolled patients varied considerably, especially when comparing either the VSRR group or the mechanical Bentall group with the Bentall group with a biological conduit. Furthermore, we did not have detailed data on the aortic valve leaflets morphology in patients undergoing a Bentall operation, in order to say if valvepreserving operation would have been possible in all these patients. A more detailed description of aortic valve leaflet ADULT CARDIAC pathologies and prospective randomized studies are needed to confirm the findings of the present retrospective study.
CONCLUSION
Our findings suggest that aortic valve-sparing procedures should be the first choice in patients with AAA, with or without concomitant AR, and should be performed whenever technically feasible. If the Bentall operation is unavoidable, one should consider a biological prosthesis also in patients younger than 65 years of age, in order to avoid late bleeding complications. Additional detailed observation and prospective randomization are necessary in order to confirm the findings of the present retrospective study.
APPENDIX. CONFERENCE DISCUSSION
Dr G. Stefanelli (Modena, Italy): I have analysed this paper with full attention. Undoubtedly, the topic is very interesting and, as you pointed out in the manuscript, there are very few published papers comparing the results of the different surgical options available for the treatment of aortic root and aortic valve pathology. However, this study is affected by some bias and drawbacks. Some are already reported in the manuscript in the section 'study limitations,' namely, the retrospective and non-randomized study design, the extreme variability of important preoperative characteristics of the three patient groups, such as age, functional class, ejection fraction (seriously compromising the homogeneity), and finally the incomplete follow-up, meaning that the patients, for instance, in the biological Bentall group, were older and sicker compared to the patients in the valve-sparing group.
There are also some discrepancies between the demographic and the operative data reported in your tables: for instance, in the valve-sparing group, mitral disease was present in more than 37% of patients but it was treated in less than 1% of patients.
In conclusion, I find the subject of this study very exciting and I congratulate the authors for their results in this difficult field, but I don't believe that any useful message concerning the intermediate and long-term survival of patients operated on for aortic root replacement can be derived from your analysis.
I have three questions to address to the authors. First, is this a single surgeon or a team surgeon experience? Because you know that surgical skill can make a difference regarding the short-and long-term functional results, especially in the reimplantation group or valve-sparing group. Second, why, this being a retrospective and not a randomized study, did the authors not select a smaller sample of more homogeneous patients and avoid emergency cases in order to obtain a more reliable and accurate analysis? And finally, can you comment on the discrepancies between the demographic features and the operative data in the tables?
Dr Badiu: It is a difficult topic and, of course, the patients are not completely similar. I will start with your third question first of all, regarding the tables. We depicted in our tables the demographics of our patients. If a patient presented with a second degree mitral or tricuspid valve regurgitation, we haven't had to operate on the valve, but the valve disease was counted in the demographics, which is why the discrepancy is there. There is also a discrepancy in the described coronary artery disease compared to the patients who received CABG. Due to problems with the right coronary artery in patients presenting with type A dissection, we had to perform a CABG operation also in those patients, even if they haven't had any coronary artery disease. This explains the discrepancy.
It is very important to mention that the groups are not similar, but as I pointed out in our manuscript, the patients in the mechanical Bentall group are not so different to those in the valve-sparing group, although they are not pairmatched. The only major difference is the higher type A dissection rate in the Bentall group. This is a result of our surgical strategy during the early period of this study. We never performed valve-sparing procedures in the early 2000's in the type A dissections.
Regarding your first question, it is not a single surgeon study. There is a group of senior surgeons who perform these Bentall operations and only a few, three to four, surgeons who perform the valve-sparing root replacements. And we have this expected learning curve with the valve-sparing procedures. When we started with the valve-sparing procedures, we never performed a valvuloplasty concomitant with the sparing procedure, if the aortic valve was competent. During the last five years we changed our strategy. Now we are looking for the geometry of the aortic valve and the aortic root. Even if the valve is competent, it is important to achieve a good coaptation area and no prolapse of the leaflets.
Dr Stefanelli: So your strategy has changed since the time since you started? Dr Badiu: Yes. That is what I wanted to point out, that we changed our strategy. We extended the indications for valve-sparing root replacement also for patients presenting with type A dissection, depending on the patient's clinical state, of course.
Dr M. Sousa Uva (Lisbon, Portugal): I just wanted to ask you a question and make a comment. You have said that you had a double population in the valvesparing operation, those without and those with aortic insufficiency. I wonder if you have looked at the echo results in those patients with aortic insufficiency versus those that had only aortic root dilatation and if there is any influence on the reoperation rate in those patients?
Dr Badiu: That is a good question. I haven't presented the data, but we looked for this insufficiency in our valve-sparing patients. I can tell you that we have (excluding, of course, the eight reoperated valve-sparing patients) a freedom from moderate regurgitation of 100% up until now. As we reported in a previous paper, there is a slight difference between the groups with severe regurgitation and those without or with less than severe regurgitation. When you look at these eight reoperated patients, you will see that four of them received a valve-sparing procedure about nine years ago. They were diagnosed with Marfan syndrome. We performed a Yacoub procedure at that time in these patients without stabilizing the aortic ring. That is why these four patients had severe recurrent regurgitation.
